Novel strategies for cancer immunotherapy: counter-immunoediting therapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel strategies for cancer immunotherapy: counter-immunoediting therapy
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 16, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-04-13
DOI
10.1186/s13045-023-01430-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pericytes in the tumor microenvironment
- (2023) Zhongyi Jiang et al. CANCER LETTERS
- Phase I clinical trial of DNA methyltransferase inhibitor decitabine and PARP inhibitor talazoparib combination therapy in relapsed/refractory acute myeloid leukemia
- (2022) Maria R. Baer et al. CLINICAL CANCER RESEARCH
- Crosstalk between cancer-associated fibroblasts and immune cells in peritoneal metastasis: inhibition in the migration of M2 macrophages and mast cells by Tranilast
- (2022) Yusuke Nakamura et al. Gastric Cancer
- Evaluating the Patient With a Pulmonary Nodule
- (2022) Peter J. Mazzone et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and Safety of Sintilimab Plus Anlotinib for PD-L1–Positive Recurrent or Metastatic Cervical Cancer: A Multicenter, Single-Arm, Prospective Phase II Trial
- (2022) Qin Xu et al. JOURNAL OF CLINICAL ONCOLOGY
- Hallmarks of Cancer: New Dimensions
- (2022) Douglas Hanahan Cancer Discovery
- Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer
- (2022) Emma Kurz et al. CANCER CELL
- Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer
- (2022) Huocong Huang et al. CANCER CELL
- Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma
- (2022) Markus W. Löffler et al. CLINICAL CANCER RESEARCH
- Protein Kinase C α and β compensate for each other to promote stem cell factor‐mediated KIT phosphorylation, mast cell viability and proliferation
- (2022) Lakshminarayan Reddy Teegala et al. FASEB JOURNAL
- Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment
- (2022) Carolina J. Garcia Garcia et al. GASTROENTEROLOGY
- Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity
- (2022) Takumi Maruhashi et al. IMMUNITY
- Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses
- (2022) Karl L. Banta et al. IMMUNITY
- Lung adenocarcinoma manifesting as subsolid nodule potentially represents tumour in the equilibrium phase of immunoediting
- (2022) Rongxin Xiao et al. IMMUNOLOGY
- Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy
- (2022) Masahiro Okada et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
- (2022) Yan Tie et al. Journal of Hematology & Oncology
- A vaccine targeting resistant tumours by dual T cell plus NK cell attack
- (2022) Soumya Badrinath et al. NATURE
- Autoreactive CD8+ T cells are restrained by an exhaustion-like program that is maintained by LAG3
- (2022) Stephanie Grebinoski et al. NATURE IMMUNOLOGY
- Carcinoma Associated Mesenchymal Stem/Stromal Cells – Architects of the Pro-tumorigenic tumor microenvironment
- (2022) Len Frisbie et al. STEM CELLS
- CD4+ T cells are required to improve the efficacy of CIK therapy in non-small cell lung cancer
- (2022) Shaochuan Liu et al. Cell Death & Disease
- Vitamin E Enhances Cancer Immunotherapy by Reinvigorating Dendritic Cells via Targeting Checkpoint SHP1
- (2022) Xiangliang Yuan et al. Cancer Discovery
- Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity
- (2022) Pierre-Louis Bernard et al. Journal for ImmunoTherapy of Cancer
- Safety and Efficacy of Sintilimab and Anlotinib as First Line Treatment for Advanced Hepatocellular Carcinoma (KEEP-G04): A Single-Arm Phase 2 Study
- (2022) Xiaofeng Chen et al. Frontiers in Oncology
- EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment
- (2022) Clelia Madeddu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The metastatic spread of breast cancer accelerates during sleep
- (2022) Zoi Diamantopoulou et al. NATURE
- Enriched circulating and tumor-resident TGF-β+ regulatory B cells in patients with melanoma promote FOXP3+ Tregs
- (2022) Robert J Harris et al. OncoImmunology
- CD155 in tumor progression and targeted therapy
- (2022) Meixiao Zhan et al. CANCER LETTERS
- LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity
- (2022) Akshay T. Krishnamurty et al. NATURE
- Vitamin C enhances NF-κB-driven epigenomic reprogramming and boosts the immunogenic properties of dendritic cells
- (2022) Octavio Morante-Palacios et al. NUCLEIC ACIDS RESEARCH
- Nutrition, Immunosenescence, and Infectious Disease: An Overview of the Scientific Evidence on Micronutrients and on Modulation of the Gut Microbiota
- (2022) Philip C Calder et al. Advances in Nutrition
- Lipids for CD8+ TILs: Beneficial or harmful?
- (2022) Duojiao Wu et al. Frontiers in Immunology
- Microenvironmental ammonia enhances T cell exhaustion in colorectal cancer
- (2022) Hannah N. Bell et al. Cell Metabolism
- Inhibition of CD39 unleashes macrophage antibody-dependent cellular phagocytosis against B-cell lymphoma
- (2022) Mika Casey et al. LEUKEMIA
- Diverse effects of obesity on antitumor immunity and immunotherapy
- (2022) Lydia Dyck et al. TRENDS IN MOLECULAR MEDICINE
- CD73 Inhibits cGAS–STING and Cooperates with CD39 to Promote Pancreatic Cancer
- (2022) Célia Jacoberger-Foissac et al. Cancer Immunology Research
- PD-1/LAG-3 bispecific antibody potentiates T cell activation and increases antitumor efficacy
- (2022) Ning Shi et al. Frontiers in Immunology
- Anti-CD73 antibody activates human B cells, enhances humoral responses and induces redistribution of B cells in patients with cancer
- (2022) Richard A Miller et al. Journal for ImmunoTherapy of Cancer
- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response
- (2021) Michelle von Locquenghien et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor
- (2021) Yuying Liu et al. NATURE IMMUNOLOGY
- Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma
- (2021) Zhuting Hu et al. NATURE MEDICINE
- Fueling the Fire: Inflammatory Forms of Cell Death and Implications for Cancer Immunotherapy
- (2021) Sheera R. Rosenbaum et al. Cancer Discovery
- Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity
- (2021) Tuxiong Huang et al. GUT
- Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control
- (2021) Claire Lhuillier et al. JOURNAL OF CLINICAL INVESTIGATION
- mRNA vaccine for cancer immunotherapy
- (2021) Lei Miao et al. Molecular Cancer
- Immunogenicity of CAR T cells in cancer therapy
- (2021) Dimitrios L. Wagner et al. Nature Reviews Clinical Oncology
- Therapeutic applications of the cancer immunoediting hypothesis
- (2021) Rupen Desai et al. SEMINARS IN CANCER BIOLOGY
- Therapeutically increasing MHC-I expression potentiates immune checkpoint blockade
- (2021) Shengqing Stan Gu et al. Cancer Discovery
- Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
- (2021) Karthik Dhatchinamoorthy et al. Frontiers in Immunology
- Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity
- (2021) Yao He et al. Cell Metabolism
- Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC
- (2021) Tianqing Chu et al. Journal of Thoracic Oncology
- Epigenetic reprogramming of tumor cell–intrinsic STING function sculpts antigenicity and T cell recognition of melanoma
- (2021) Rana Falahat et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer
- (2021) Christopher S. Garris et al. Science Translational Medicine
- Exercise Training Improves Tumor Control by Increasing CD8+ T-cell Infiltration via CXCR3 Signaling and Sensitizes Breast Cancer to Immune Checkpoint Blockade
- (2021) Igor L. Gomes-Santos et al. Cancer Immunology Research
- Adoptive T Cell Therapy for Solid Tumors: Pathway to Personalized Standard of Care
- (2021) Shuyang S. Qin et al. Cells
- The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer
- (2021) William A. Freed-Pastor et al. CANCER CELL
- Pericytes augment glioblastoma cell resistance to temozolomide through CCL5-CCR5 paracrine signaling
- (2021) Xiao-Ning Zhang et al. CELL RESEARCH
- Anti-PD1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer with Actionable Oncogenic Driver Mutations
- (2021) Edouard Dantoing et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC
- (2021) Mark A. Socinski et al. Journal of Thoracic Oncology
- Overcoming Chemotherapy Resistance in SCLC
- (2021) Brett H. Herzog et al. Journal of Thoracic Oncology
- Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma
- (2021) Jooeun Bae et al. LEUKEMIA
- Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial
- (2021) Benjamin C. Creelan et al. NATURE MEDICINE
- The MYC oncogene — the grand orchestrator of cancer growth and immune evasion
- (2021) Renumathy Dhanasekaran et al. Nature Reviews Clinical Oncology
- Improving Sleep Quality Leads to Better Mental Health: A Meta-Analysis of Randomised Controlled Trials
- (2021) Alexander J. Scott et al. SLEEP MEDICINE REVIEWS
- Cell cycle on the crossroad of tumorigenesis and cancer therapy
- (2021) Jing Liu et al. TRENDS IN CELL BIOLOGY
- PD-1, PD-L1, and PD-L2 Gene Expression and Tumor Infiltrating Lymphocytes in Canine Melanoma
- (2021) Valentina B. Stevenson et al. VETERINARY PATHOLOGY
- Nutritional intake and bone health
- (2021) René Rizzoli et al. Lancet Diabetes & Endocrinology
- Pericytes cross-talks within the tumor microenvironment
- (2021) Caroline C. Picoli et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pancreatic Adenocarcinoma
- (2021) Miles Piper et al. CLINICAL CANCER RESEARCH
- Anlotinib Induces a T Cell–Inflamed Tumor Microenvironment by Facilitating Vessel Normalization and Enhances the Efficacy of PD-1 Checkpoint Blockade in Neuroblastoma
- (2021) Yudong Su et al. CLINICAL CANCER RESEARCH
- Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity
- (2021) Bola S. Hanna et al. IMMUNITY
- Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
- (2021) Enyong Dai et al. Molecular Cancer
- EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatment
- (2021) Alex Friedlaender et al. Nature Reviews Clinical Oncology
- Targeting cancer metabolism in the era of precision oncology
- (2021) Zachary E. Stine et al. NATURE REVIEWS DRUG DISCOVERY
- Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity
- (2021) Brooke Prinzing et al. Science Translational Medicine
- Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma
- (2021) Alexander H. Lee et al. Nature Communications
- LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade
- (2021) Yi Liu et al. Nature Communications
- Reversing T-cell Exhaustion in Cancer: Lessons Learned from PD-1/PD-L1 Immune Checkpoint Blockade
- (2021) Natalija Budimir et al. Cancer Immunology Research
- The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity
- (2020) Alexandra Schnell et al. CELL RESEARCH
- Immunosurveillance and Immunoediting of Lung Cancer: Current Perspectives and Challenges
- (2020) Kei Kunimasa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Antiangiogenic immunotherapy suppresses desmoplastic and chemoresistant intestinal tumors in mice
- (2020) Simone Ragusa et al. JOURNAL OF CLINICAL INVESTIGATION
- CAR T cells: continuation in a revolution of immunotherapy
- (2020) Anurag K Singh et al. LANCET ONCOLOGY
- Neoadjuvant checkpoint blockade for cancer immunotherapy
- (2020) Suzanne L. Topalian et al. SCIENCE
- Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis
- (2020) Nikos Papadimitriou et al. Nature Communications
- Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non–small cell lung cancer
- (2020) Eri Sugiyama et al. Science Immunology
- Acquired Resistance to Immune Checkpoint Inhibitors
- (2020) Adam J. Schoenfeld et al. CANCER CELL
- CD8+ T-cell-mediated immunoediting influences genomic evolution and immune evasion in murine gliomas
- (2020) Joshua Robert Kane et al. CLINICAL CANCER RESEARCH
- Exercise retards hepatocarcinogenesis in obese mice independently of weight control
- (2020) Arfianti Arfianti et al. JOURNAL OF HEPATOLOGY
- Anti-PD-1 antibody combined with chemotherapy suppresses the growth of mesothelioma by reducing myeloid-derived suppressor cells
- (2020) Kenji Otsuka et al. LUNG CANCER
- The Impact of Radiation Therapy on Innate and Adaptive Tumor Immunity
- (2020) Andrew Brandmaier et al. SEMINARS IN RADIATION ONCOLOGY
- anlotinib alters tumor immune microenvironment by downregulating PD-L1 expression on vascular endothelial cells
- (2020) Shaochuan Liu et al. Cell Death & Disease
- Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma
- (2020) Nathiya Muthalagu et al. Cancer Discovery
- Gut Microbiota Modulate CD8 T Cell Responses to Influence Colitis-Associated Tumorigenesis
- (2020) Amy I. Yu et al. Cell Reports
- Anti-VEGF Treatment Enhances CD8+ T-cell Antitumor Activity by Amplifying Hypoxia
- (2020) Patricia E. de Almeida et al. Cancer Immunology Research
- Targeting Inflammation Driven by HMGB1
- (2020) Huan Yang et al. Frontiers in Immunology
- Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer
- (2020) Houssein Abdul Sater et al. Journal for ImmunoTherapy of Cancer
- Apatinib prevents natural killer cell dysfunction to enhance the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinoma
- (2020) Yinli Yang et al. CANCER GENE THERAPY
- Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancer
- (2020) Yinli Yang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma
- (2020) Joe-Marc Chauvin et al. CLINICAL CANCER RESEARCH
- Nutrition and immune system: from the Mediterranean diet to dietary supplementary through the microbiota
- (2020) Luigi Barrea et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- The Effects of Dietary Nutrition on Sleep and Sleep Disorders
- (2020) Mingxia Zhao et al. MEDIATORS OF INFLAMMATION
- An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
- (2020) Ugur Sahin et al. NATURE
- The Roles of CD8+ T Cell Subsets in Antitumor Immunity
- (2020) Michael St. Paul et al. TRENDS IN CELL BIOLOGY
- Synchronous ground‐glass nodules showed limited response to anti‐PD‐1/PD‐L1 therapy in patients with advanced lung adenocarcinoma
- (2020) Fengying Wu et al. Clinical and Translational Medicine
- Challenges and Opportunities for Pancreatic Cancer Immunotherapy
- (2020) Adham S. Bear et al. CANCER CELL
- The role of microenvironment in tumor angiogenesis
- (2020) Xianjie Jiang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
- (2020) Jeremy S Abramson et al. LANCET
- Targeting the epigenetic regulation of antitumour immunity
- (2020) Simon J. Hogg et al. NATURE REVIEWS DRUG DISCOVERY
- Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
- (2020) Sreya Bagchi et al. Annual Review of Pathology-Mechanisms of Disease
- Targeting MARCO and IL-37R on immunosuppressive macrophages in lung cancer blocks regulatory T cells and supports cytotoxic lymphocyte function
- (2020) Linnéa La Fleur et al. CANCER RESEARCH
- Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity
- (2020) Alison E. Ringel et al. CELL
- Entinostat plus pembrolizumab in patients with metastatic NSCLC previously treated with anti-PD-(L)1 therapy
- (2020) Matthew D. Hellmann et al. CLINICAL CANCER RESEARCH
- Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma
- (2020) Gils Roex et al. Journal of Hematology & Oncology
- Therapeutics Targeting Mutant KRAS
- (2020) Kyaw Z. Thein et al. Annual Review of Medicine
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function
- (2019) Sarah Whelan et al. Cancer Immunology Research
- Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial
- (2019) Martin Reck et al. Lancet Respiratory Medicine
- Low-dose apatinib optimizes tumor microenvironment and potentiates antitumor effect of PD-1/PD-L1 blockade in lung cancer
- (2019) Sha Zhao et al. Cancer Immunology Research
- CXCR4 signaling regulates metastatic onset by controlling neutrophil motility and response to malignant cells
- (2019) C. Tulotta et al. Scientific Reports
- T cell stemness and dysfunction in tumors are triggered by a common mechanism
- (2019) Suman Kumar Vodnala et al. SCIENCE
- A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma
- (2019) Alexander C. Huang et al. NATURE MEDICINE
- Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
- (2019) Timothy F. Cloughesy et al. NATURE MEDICINE
- CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
- (2019) Laura M. McLane et al. Annual Review of Immunology
- Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment
- (2019) Xingzhe Ma et al. Cell Metabolism
- Long-term follow-up of ground-glass nodules after 5 years of stability
- (2019) Hyun Woo Lee et al. Journal of Thoracic Oncology
- Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion
- (2019) Deepali V. Sawant et al. NATURE IMMUNOLOGY
- Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
- (2019) Noopur Raje et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Immunoediting by Innate Lymphoid Cells
- (2019) Marek Wagner et al. TRENDS IN IMMUNOLOGY
- Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies
- (2019) Ivan Perrot et al. Cell Reports
- STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models
- (2019) Weiqing Jing et al. Journal for ImmunoTherapy of Cancer
- Human colorectal cancer derived-MSCs promote tumor cells escape from senescence via P53/P21 pathway
- (2019) G. Li et al. Clinical & Translational Oncology
- Epidrugs: targeting epigenetic marks in cancer treatment
- (2019) Cristiana Libardi Miranda Furtado et al. Epigenetics
- Targeting Treg cells in cancer immunotherapy
- (2019) Atsushi Tanaka et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The combined effect of FGFR inhibition and PD-1 blockade promotes tumor-intrinsic induction of antitumor immunity
- (2019) Sangeetha Palakurthi et al. Cancer Immunology Research
- Histone-deacetylase inhibition sensitizes PD1 blockade-resistant B-cell lymphomas
- (2019) Xiaoguang Wang et al. Cancer Immunology Research
- Physical Exercise Induces Immunoregulation of TREG, M2, and pDCs in a Lung Allergic Inflammation Model
- (2019) Paula Fernandes et al. Frontiers in Immunology
- UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma
- (2019) Yochai Wolf et al. CELL
- Targeting EZH2 enhances antigen presentation, antitumor immunity and circumvents anti-PD-1 resistance in head and neck cancers
- (2019) Liye Zhou et al. CLINICAL CANCER RESEARCH
- Tracing the Equilibrium Phase of Cancer Immunoediting in Epidermal Neoplasms via Longitudinal, Intravital Imaging
- (2019) Bradley J. Kubick et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- CDK4/6 inhibitor palbociclib suppresses IgE-mediated mast cell activation
- (2019) Yi-Bo Hou et al. Journal of Translational Medicine
- PTPN2 regulates the generation of exhausted CD8+ T cell subpopulations and restrains tumor immunity
- (2019) Martin W. LaFleur et al. NATURE IMMUNOLOGY
- Stress–glucocorticoid–TSC22D3 axis compromises therapy-induced antitumor immunity
- (2019) Heng Yang et al. NATURE MEDICINE
- STING Signaling in Melanoma Cells Shapes Antigenicity and Can Promote Antitumor T-cell Activity
- (2019) Rana Falahat et al. Cancer Immunology Research
- Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity
- (2019) Zhida Liu et al. Science Immunology
- STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis
- (2019) Christina Heichler et al. GUT
- Galectin-1–driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance
- (2019) Dhanya K. Nambiar et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer
- (2019) Koji Teramoto et al. LUNG CANCER
- Activation of immunosuppressive network in the aging process
- (2019) Antero Salminen AGEING RESEARCH REVIEWS
- The co-expression characteristics of LAG3 and PD-1 on the T cells of patients with breast cancer reveal a new therapeutic strategy
- (2019) Huimin Du et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Amount and Intensity of Leisure-Time Physical Activity and Lower Cancer Risk
- (2019) Charles E. Matthews et al. JOURNAL OF CLINICAL ONCOLOGY
- Mast Cells Are Directly Activated by Cancer Cell–Derived Extracellular Vesicles by a CD73- and Adenosine-Dependent Mechanism
- (2019) Yaara Gorzalczany et al. Translational Oncology
- Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer
- (2019) Wei Li et al. Cell Death & Disease
- Adenosine Generated by Regulatory T Cells Induces CD8+ T Cell Exhaustion in Gastric Cancer through A2aR Pathway
- (2019) Linsen Shi et al. Biomed Research International
- TIGIT immune checkpoint blockade restores CD8+T cell immunity against multiple myeloma
- (2018) Camille Guillerey et al. BLOOD
- The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models
- (2018) Heinz Läubli et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
- (2018) Karolina Woroniecka et al. CLINICAL CANCER RESEARCH
- Targeting fibroblast activation protein in cancer ndash Prospects and caveats
- (2018) Aleksi Sedo Frontiers in Bioscience-Landmark
- Epithelial-mesenchymal transition leads to NK cell–mediated metastasis-specific immunosurveillance in lung cancer
- (2018) Peter J. Chockley et al. JOURNAL OF CLINICAL INVESTIGATION
- Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity
- (2018) Sabine Hoves et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Intrinsic and Extrinsic Regulation of PD-L2 Expression in Oncogene-Driven Non–Small Cell Lung Cancer
- (2018) Daisuke Shibahara et al. Journal of Thoracic Oncology
- Long-term Active Surveillance of Screening Detected Subsolid Nodules is a Safe Strategy to Reduce Overtreatment
- (2018) Mario Silva et al. Journal of Thoracic Oncology
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
- (2018) Franck Pagès et al. LANCET
- Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer
- (2018) Shang-Gin Wu et al. Molecular Cancer
- Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
- (2018) Qing Zhang et al. NATURE IMMUNOLOGY
- A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
- (2018) Daniela S. Thommen et al. NATURE MEDICINE
- Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
- (2018) Nikolaos Zacharakis et al. NATURE MEDICINE
- Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
- (2018) Patrick M. Forde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acute aerobic exercise induces a preferential mobilisation of plasmacytoid dendritic cells into the peripheral blood in man
- (2018) Frankie F. Brown et al. PHYSIOLOGY & BEHAVIOR
- MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
- (2018) Scott J. Rodig et al. Science Translational Medicine
- DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer
- (2018) Na Luo et al. Nature Communications
- Cancer-associated fibroblasts induce antigen-specific deletion of CD8+ T Cells to protect tumour cells
- (2018) Matthew A. Lakins et al. Nature Communications
- Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs
- (2018) Julie M. Diamond et al. Cancer Immunology Research
- Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
- (2018) Joy Hsu et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis
- (2018) Xian Shen et al. BMJ-British Medical Journal
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
- (2018) Miguel F. Sanmamed et al. CELL
- Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
- (2018) Jun Wang et al. CELL
- Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
- (2018) Frederick L Locke et al. LANCET ONCOLOGY
- Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin
- (2018) Simone L. Park et al. NATURE
- Metabolic reprogramming of natural killer cells in obesity limits antitumor responses
- (2018) Xavier Michelet et al. NATURE IMMUNOLOGY
- Cancer immunoediting and resistance to T cell-based immunotherapy
- (2018) Jake S. O’Donnell et al. Nature Reviews Clinical Oncology
- Turning foes to friends: targeting cancer-associated fibroblasts
- (2018) Xueman Chen et al. NATURE REVIEWS DRUG DISCOVERY
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination
- (2018) Marcus Ruscetti et al. SCIENCE
- On the Dual Role of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1) in Human Malignancies
- (2018) Andreea Calinescu et al. Journal of Immunology Research
- Regulation of Effector and Memory CD8 T Cell Differentiation by IL-2—A Balancing Act
- (2018) Vandana Kalia et al. Frontiers in Immunology
- Lifelong training improves anti-inflammatory environment and maintains the number of regulatory T cells in masters athletes
- (2017) Luciele G. Minuzzi et al. EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY
- Tyrosine Kinase Inhibitors in the Treatment of Eosinophilic Neoplasms and Systemic Mastocytosis
- (2017) Jason Gotlib HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- White Adipose Tissue Is a Reservoir for Memory T Cells and Promotes Protective Memory Responses to Infection
- (2017) Seong-Ji Han et al. IMMUNITY
- Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors
- (2017) Frederick Arce Vargas et al. IMMUNITY
- Exercise and mental health
- (2017) Kathleen Mikkelsen et al. MATURITAS
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Supplementation with tocotrienols from Bixa orellana improves the in vivo efficacy of daptomycin against methicillin-resistant Staphylococcus aureus in a mouse model of infected wound
- (2017) Elisa Pierpaoli et al. PHYTOMEDICINE
- Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade
- (2017) Martina Schmittnaegel et al. Science Translational Medicine
- Phosphatidylserine: A cancer cell targeting biomarker
- (2017) Bhupender Sharma et al. SEMINARS IN CANCER BIOLOGY
- IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting
- (2017) Kazuyoshi Takeda et al. Nature Communications
- Pericytes regulate VEGF-induced endothelial sprouting through VEGFR1
- (2017) Hanna M. Eilken et al. Nature Communications
- Glioblastoma progression is assisted by induction of immunosuppressive function of pericytes through interaction with tumor cells
- (2017) Rut Valdor et al. Oncotarget
- CXCR2+ MDSCs promote breast cancer progression by inducing EMT and activated T cell exhaustion
- (2017) Ha Zhu et al. Oncotarget
- Kras and Tumor Immunity: Friend or Foe?
- (2017) Jane Cullis et al. Cold Spring Harbor Perspectives in Medicine
- Immunosurveillance and Immunoediting of Breast Cancer via Class I MHC Receptors
- (2017) Megan M. Tu et al. Cancer Immunology Research
- Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer
- (2017) Yohei Masugi et al. Cancer Immunology Research
- Therapeutic efficacy of combined vaccination against tumor pericyte-associated antigens DLK1 and DLK2 in mice
- (2017) Kellsye Paula L. Fabian et al. OncoImmunology
- Zinc Modulates Endotoxin-Induced Human Macrophage Inflammation through ZIP8 Induction and C/EBPβ Inhibition
- (2017) Charlie J. Pyle et al. PLoS One
- Effect of zinc supplementation on serum zinc concentration and T cell proliferation in nursing home elderly: a randomized, double-blind, placebo-controlled trial
- (2016) Junaidah B Barnett et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Psychological distress and salivary secretory immunity
- (2016) C.G. Engeland et al. BRAIN BEHAVIOR AND IMMUNITY
- Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses
- (2016) Arabella Young et al. CANCER CELL
- Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy
- (2016) Xiaohong Wang et al. CANCER RESEARCH
- Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution
- (2016) Line Pedersen et al. Cell Metabolism
- Emerging Opportunities and Challenges in Cancer Immunotherapy
- (2016) T. L. Whiteside et al. CLINICAL CANCER RESEARCH
- The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
- (2016) P. S. Hegde et al. CLINICAL CANCER RESEARCH
- The Pathophysiologic Role of Disrupted Circadian and Neuroendocrine Rhythms in Breast Carcinogenesis
- (2016) Lonnele J. Ball et al. ENDOCRINE REVIEWS
- Mast cells as therapeutic target in cancer
- (2016) Domenico Ribatti EUROPEAN JOURNAL OF PHARMACOLOGY
- T Cell Factor 1-Expressing Memory-like CD8 + T Cells Sustain the Immune Response to Chronic Viral Infections
- (2016) Daniel T. Utzschneider et al. IMMUNITY
- CD4 + CD25 + regulatory T cells in tumor immunity
- (2016) Xin Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- CD73 Inhibition Shifts Cardiac Macrophage Polarization toward a Microbicidal Phenotype and Ameliorates the Outcome of Experimental Chagas Cardiomyopathy
- (2016) Nicolás Eric Ponce et al. JOURNAL OF IMMUNOLOGY
- PD-L1 Expression in Lung Cancer
- (2016) Hui Yu et al. Journal of Thoracic Oncology
- Antiangiogenic therapy in oncology: current status and future directions
- (2016) Gordon C Jayson et al. LANCET
- Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism
- (2016) Wei Yang et al. NATURE
- Ionic immune suppression within the tumour microenvironment limits T cell effector function
- (2016) Robert Eil et al. NATURE
- Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
- (2016) Se Jin Im et al. NATURE
- NK cells and type 1 innate lymphoid cells: partners in host defense
- (2016) Hergen Spits et al. NATURE IMMUNOLOGY
- Cancer metabolism: a therapeutic perspective
- (2016) Ubaldo E. Martinez-Outschoorn et al. Nature Reviews Clinical Oncology
- T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
- (2016) Eric Tran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Downregulation of CXCL12 in mesenchymal stromal cells by TGFβ promotes breast cancer metastasis
- (2016) P F Yu et al. ONCOGENE
- Exercise-induced B cell mobilisation: Preliminary evidence for an influx of immature cells into the bloodstream
- (2016) J.E. Turner et al. PHYSIOLOGY & BEHAVIOR
- Human Mesenchymal Stem Cell-Derived Microvesicles Prevent the Rupture of Intracranial Aneurysm in Part by Suppression of Mast Cell Activation via a PGE2-Dependent Mechanism
- (2016) Jia Liu et al. STEM CELLS
- Exercise-Dependent Regulation of NK Cells in Cancer Protection
- (2016) Manja Idorn et al. TRENDS IN MOLECULAR MEDICINE
- The PDGF-BB-SOX7 axis-modulated IL-33 in pericytes and stromal cells promotes metastasis through tumour-associated macrophages
- (2016) Yunlong Yang et al. Nature Communications
- Management of malignant colon polyps: Current status and controversies
- (2016) Cary B Aarons et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The clinical use of DNA methyltransferase inhibitors in myelodysplastic syndromes
- (2015) Abdallah Abou Zahr et al. Expert Review of Anticancer Therapy
- Regulatory B Cells: Origin, Phenotype, and Function
- (2015) Elizabeth C. Rosser et al. IMMUNITY
- Exercise-induced Natural Killer Cell Activation is Driven by Epigenetic Modifications
- (2015) P. Zimmer et al. INTERNATIONAL JOURNAL OF SPORTS MEDICINE
- Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation
- (2015) Nan Chen et al. Journal of Thoracic Oncology
- PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
- (2015) S. P. Patel et al. MOLECULAR CANCER THERAPEUTICS
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- microRNA-22 downregulation of galectin-9 influences lymphocyte apoptosis and tumor cell proliferation in liver cancer
- (2015) QIANQIAN YANG et al. ONCOLOGY REPORTS
- Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses
- (2015) Jun Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Patrolling monocytes control tumor metastasis to the lung
- (2015) R. N. Hanna et al. SCIENCE
- The Next Hurdle in Cancer Immunotherapy: Overcoming the Non–T-Cell–Inflamed Tumor Microenvironment
- (2015) Thomas F. Gajewski SEMINARS IN ONCOLOGY
- Mesenchymal Stromal Cells Prevent Allostimulation In Vivo and Control Checkpoints of Th1 Priming: Migration of Human DC to Lymph Nodes and NK Cell Activation
- (2015) C. Consentius et al. STEM CELLS
- Requirement for Innate Immunity and CD90+ NK1.1- Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy
- (2015) M. Moskalenko et al. Cancer Immunology Research
- Expression of Programmed Cell Death 1 Ligand 2 (PD-L2) Is a Distinguishing Feature of Primary Mediastinal (Thymic) Large B-cell Lymphoma and Associated With PDCD1LG2 Copy Gain
- (2014) Min Shi et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
- (2014) Robert J. Johnston et al. CANCER CELL
- Ly49 Family Receptors Are Required for Cancer Immunosurveillance Mediated by Natural Killer Cells
- (2014) M. M. Tu et al. CANCER RESEARCH
- LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses
- (2014) F. Xu et al. CANCER RESEARCH
- Mesenchymal Stem Cells Use IDO to Regulate Immunity in Tumor Microenvironment
- (2014) W. Ling et al. CANCER RESEARCH
- Galectin-3 in cancer
- (2014) Lin Song et al. CLINICA CHIMICA ACTA
- New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape
- (2014) Deepak Mittal et al. CURRENT OPINION IN IMMUNOLOGY
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
- (2014) Seng-Ryong Woo et al. IMMUNITY
- Effects of stress on immune function: the good, the bad, and the beautiful
- (2014) Firdaus S. Dhabhar IMMUNOLOGIC RESEARCH
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- (2014) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses
- (2014) Bertrand Coiffier et al. Journal of Hematology & Oncology
- Neoadjuvant anti-tumor vaccination prior to surgery enhances survival
- (2014) Scott A Fisher et al. Journal of Translational Medicine
- TGF-β upregulates CD70 expression and induces exhaustion of effector memory T cells in B-cell non-Hodgkin’s lymphoma
- (2014) Z-Z Yang et al. LEUKEMIA
- CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
- (2014) Yu-Hwa Huang et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
- (2014) Gregory T Motz et al. NATURE MEDICINE
- Interleukin-35 induces regulatory B cells that suppress autoimmune disease
- (2014) Ren-Xi Wang et al. NATURE MEDICINE
- Glioblastoma: A Pathogenic Crosstalk between Tumor Cells and Pericytes
- (2014) Elisabetta M. Caspani et al. PLoS One
- Human Umbilical Cord-Derived Mesenchymal Stem Cells Utilize Activin-A to Suppress Interferon-γ Production by Natural Killer Cells
- (2014) Debanjana Chatterjee et al. Frontiers in Immunology
- Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes
- (2013) J. Ruan et al. BLOOD
- Chemoimmunotherapy: reengineering tumor immunity
- (2013) Gang Chen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Anti-CD20 Antibody Promotes Cancer Escape via Enrichment of Tumor-Evoked Regulatory B Cells Expressing Low Levels of CD20 and CD137L
- (2013) M. Bodogai et al. CANCER RESEARCH
- Oncogenes and angiogenesis: a way to personalize anti-angiogenic therapy?
- (2013) Alessia Bottos et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer
- (2013) Helen Angell et al. CURRENT OPINION IN IMMUNOLOGY
- Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism
- (2013) Tim Vanuytsel et al. GUT
- Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
- (2013) Laurence Zitvogel et al. IMMUNITY
- Inhibition of Breast Cancer Metastasis by Resveratrol-Mediated Inactivation of Tumor-Evoked Regulatory B Cells
- (2013) C. Lee-Chang et al. JOURNAL OF IMMUNOLOGY
- Antitumor Effect of Paclitaxel Is Mediated by Inhibition of Myeloid-Derived Suppressor Cells and Chronic Inflammation in the Spontaneous Melanoma Model
- (2013) A. Sevko et al. JOURNAL OF IMMUNOLOGY
- Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
- (2013) Jérôme Galon et al. JOURNAL OF PATHOLOGY
- MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells
- (2013) P. Leone et al. JNCI-Journal of the National Cancer Institute
- Human papillomavirus and cervical cancer
- (2013) Emma J Crosbie et al. LANCET
- Exercise Attenuates M1 Macrophages and CD8+ T Cells in the Adipose Tissue of Obese Mice
- (2013) NORIAKI KAWANISHI et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
- IL-17 mediates resistance to anti-VEGF therapy
- (2013) Eleni Maniati et al. NATURE MEDICINE
- Therapeutic Effects of Anti-CD115 Monoclonal Antibody in Mouse Cancer Models through Dual Inhibition of Tumor-Associated Macrophages and Osteoclasts
- (2013) Laetitia Fend et al. PLoS One
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In Vitro Evidence of the Presence of Mesenchymal Stromal Cells in Cervical Cancer and Their Role in Protecting Cancer Cells from Cytotoxic T Cell Activity
- (2013) Juan J. Montesinos et al. STEM CELLS AND DEVELOPMENT
- The MHC I loading complex: a multitasking machinery in adaptive immunity
- (2013) Sabine Hulpke et al. TRENDS IN BIOCHEMICAL SCIENCES
- CD39 and CD73 in immunity and inflammation
- (2013) Luca Antonioli et al. TRENDS IN MOLECULAR MEDICINE
- Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity
- (2013) L.-C. S. Wang et al. Cancer Immunology Research
- Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells
- (2013) M. J. Selby et al. Cancer Immunology Research
- Lessons Learned from Randomized Clinical Trials of Micronutrient Supplementation for Cancer Prevention
- (2012) Susan T. Mayne et al. Annual Review of Nutrition
- Vitamin C Promotes Maturation of T-Cells
- (2012) Jared Manning et al. ANTIOXIDANTS & REDOX SIGNALING
- Adoptive T-Cell Therapy Using Autologous Tumor-Infiltrating Lymphocytes for Metastatic Melanoma
- (2012) Richard Wu et al. CANCER JOURNAL
- VEGFA-VEGFR Pathway Blockade Inhibits Tumor-Induced Regulatory T-cell Proliferation in Colorectal Cancer
- (2012) M. Terme et al. CANCER RESEARCH
- The critical role of mast cell-derived hypoxia-inducible factor-1α in human and mice melanoma growth
- (2012) Hyun-Ja Jeong et al. INTERNATIONAL JOURNAL OF CANCER
- Long-Term Surveillance of Ground-Glass Nodules: Evidence from the MILD Trial
- (2012) Silva Mario et al. Journal of Thoracic Oncology
- Galectin-9 promotes TGF-β1-dependent induction of regulatory T cells via the TGF-β/Smad signaling pathway
- (2012) KUN LV et al. Molecular Medicine Reports
- Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
- (2012) Shigeki Chiba et al. NATURE IMMUNOLOGY
- ENTPD1/CD39 is a promising therapeutic target in oncology
- (2012) J Bastid et al. ONCOGENE
- Chemotherapeutics and Radiation Stimulate MHC Class I Expression through Elevated Interferon-beta Signaling in Breast Cancer Cells
- (2012) Shan Wan et al. PLoS One
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma
- (2011) C M den Hoed et al. BRITISH JOURNAL OF CANCER
- Endogenous T Cell Responses to Antigens Expressed in Lung Adenocarcinomas Delay Malignant Tumor Progression
- (2011) Michel DuPage et al. CANCER CELL
- The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy
- (2011) P N Kelly et al. CELL DEATH AND DIFFERENTIATION
- Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production
- (2011) Karen McLean et al. JOURNAL OF CLINICAL INVESTIGATION
- CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells
- (2011) Zhangguo Chen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Sleep after Vaccination Boosts Immunological Memory
- (2011) T. Lange et al. JOURNAL OF IMMUNOLOGY
- Angiogenesis Inhibitors: Current Strategies and Future Prospects
- (2010) K. M. Cook et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Biobehavioral, Immune, and Health Benefits following Recurrence for Psychological Intervention Participants
- (2010) B. L. Andersen et al. CLINICAL CANCER RESEARCH
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+T cell dysfunction in melanoma patients
- (2010) Julien Fourcade et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mechanisms of HBV-related hepatocarcinogenesis
- (2010) Christine Neuveut et al. JOURNAL OF HEPATOLOGY
- Autocrine TGF- and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts
- (2010) Y. Kojima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2
- (2009) G. M. Spaggiari et al. BLOOD
- Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses
- (2009) W M Liu et al. BRITISH JOURNAL OF CANCER
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
- (2009) Zvi G. Fridlender et al. CANCER CELL
- Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer
- (2009) P.-Y. Pan et al. CANCER RESEARCH
- Neoadjuvant Vaccination Provides Superior Protection against Tumor Relapse following Surgery Compared with Adjuvant Vaccination
- (2009) N. Grinshtein et al. CANCER RESEARCH
- Spontaneous regression of metastases from melanoma: review of the literature
- (2009) Louise Vennegaard Kalialis et al. MELANOMA RESEARCH
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients
- (2008) J. H. Finke et al. CLINICAL CANCER RESEARCH
- NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy
- (2008) Nadia Guerra et al. IMMUNITY
- Selective expansion of a subset of exhausted CD8 T cells by PD-L1 blockade
- (2008) S. D. Blackburn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CTLA-4 Control over Foxp3+ Regulatory T Cell Function
- (2008) K. Wing et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now